VMV Hypoallergenics

VMV Hypoallergenics is a research-driven skincare and dermatology company founded in 1979 by world-renowned dermatologist Dr. Vermén M. Verallo-Rowell. The company is distinguished by its proprietary VH-Rating system, a validated methodology that tracks and excludes known allergens identified by the North American Contact Dermatitis Group and the European Surveillance System on Contact Allergies. Their extensive product portfolio includes clinically tested treatments for acne, hyperpigmentation, and sensitive skin, as well as specialized pediatric and sun care lines. Every product undergoes rigorous clinical testing, including randomized double-blind controlled trials, to ensure high safety and efficacy standards. Headquartered in New York with significant research and clinical facilities in the Philippines, VMV Hypoallergenics serves as a global leader in evidence-based, hypoallergenic skincare for both clinical and retail markets.